tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 2 analysts with an average price target of $69.25. This is a potential upside of $12.75 (22.57%) from yesterday's end of day stock price of $56.5.
Supernus Pharmaceuticals's activity chart (see below) currently has 100 price targets and 73 ratings on display. The stock rating distribution of SUPN is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 76.83% with an average time for these price targets to be met of 314.78 days.
Highest price target for SUPN is $65, Lowest price target is $63, average price target is $64.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 08-Oct-2025. First documented stock forecast 11-Mar-2015.
Currently out of the existing stock ratings of SUPN, 3 are a HOLD (50%), 3 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$65
$12.17 (23.04%)
$40
23 days ago
(08-Oct-2025)
22/24 (91.67%)
$15.49 (31.29%)
337
Buy
$63
$10.17 (19.25%)
$46
1 months 2 days ago
(29-Sep-2025)
3/4 (75%)
$15.21 (31.83%)
119
Buy
$44
$-8.83 (-16.71%)
$40
3 years 11 months ago
(30-Nov-2021)
14/15 (93.33%)
$13.15 (42.63%)
461
Buy
$35
$-17.83 (-33.75%)
$50
5 years 2 months 13 days ago
(18-Aug-2020)
4/4 (100%)
$11.6 (49.57%)
825
Hold
$23
5 years 6 months 16 days ago
(15-Apr-2020)
5/7 (71.43%)
$1.85 (8.75%)
100
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?
